|
44
|
273
|
2rs31 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rmu2 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
47
|
255
|
2rs32 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rm22 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
43
|
273
|
2rs51 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rs54 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
42
|
273
|
2rs11 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2rmu3 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
152
|
497
|
2uuwA |
2.75 angstrom structure of the d347g d348g mutant structure of sapporo virus rdrp polymerase |
|
47
|
255
|
2rs52 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rs34 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rr14 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rs12 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2rmu4 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
43
|
273
|
2rm21 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rs53 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2rr12 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
44
|
273
|
2rr11 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rs13 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rr13 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
37
|
236
|
2rm23 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
273
|
2rmu1 |
Three-dimensional structures of drug-resistant mutants of human rhinovirus 14 |
|
2
|
40
|
2rm24 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r072 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r064 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
7
|
97
|
2r29A |
Neutralization of dengue virus by a serotype cross-reactive antibody elucidated by cryoelectron microscopy and x-ray crystallography |
|
38
|
236
|
2r063 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r073 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
273
|
2r041 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r074 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r042 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
41
|
273
|
2r071 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
42
|
273
|
2r061 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
47
|
255
|
2r062 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
38
|
236
|
2r043 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
2
|
40
|
2r044 |
Structural analysis of antiviral agents that interact with the capsid of human rhinoviruses |
|
6
|
97
|
2r69A |
Crystal structure of fab 1a1d-2 complexed with e-diii of dengue virus at 3.8 angstrom resolution |
|
108
|
431
|
2qeqA |
Crystal structure of kunjin virus ns3 helicase |
|
1
|
16
|
2qv1C |
Crystal structure of hcv ns3-4a v36m mutant |
|
84
|
262
|
2pxaA |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah and gtpg |
|
82
|
262
|
2px2A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (monoclinic form 1) |
|
91
|
265
|
2px5A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (orthorhombic crystal form) |
|
89
|
263
|
2pxcA |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sam and gtpa |
|
85
|
263
|
2px4A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah (monoclinic form 2) |
|
87
|
264
|
2px8A |
Crystal structure of the murray valley encephalitis virus ns5 2'-o methyltransferase domain in complex with sah and 7m-gtp |
|
41
|
300
|
2plv1 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
61
|
268
|
2plv2 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
38
|
235
|
2plv3 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
3
|
68
|
2plv4 |
Structural factors that control conformational transitions and serotype specificity in type 3 poliovirus |
|
12
|
101
|
2p5pA |
Crystal structure analysis of the west nile virus envelope (e) protein domain iii |
